vs
Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $41.3M, roughly 1.4× Northfield Bancorp, Inc.). Vanda Pharmaceuticals Inc. runs the higher net margin — -246.8% vs -1545.5%, a 1298.8% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs 7.6%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-29.5M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs 9.8%).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
NFBK vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.3M | $57.2M |
| Net Profit | $-27.4M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | -1263.3% | -70.5% |
| Net Margin | -1545.5% | -246.8% |
| Revenue YoY | 12.7% | 7.6% |
| Net Profit YoY | -343.6% | -2774.3% |
| EPS (diluted) | $-0.68 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.3M | $57.2M | ||
| Q3 25 | $39.2M | $56.3M | ||
| Q2 25 | $38.9M | $52.6M | ||
| Q1 25 | $34.8M | $50.0M | ||
| Q4 24 | $36.7M | $53.2M | ||
| Q3 24 | $31.8M | $47.7M | ||
| Q2 24 | $31.5M | $50.5M | ||
| Q1 24 | $31.3M | $47.5M |
| Q4 25 | $-27.4M | $-141.2M | ||
| Q3 25 | $10.8M | $-22.6M | ||
| Q2 25 | $9.6M | $-27.2M | ||
| Q1 25 | $7.9M | $-29.5M | ||
| Q4 24 | $11.3M | $-4.9M | ||
| Q3 24 | $6.5M | $-5.3M | ||
| Q2 24 | $6.0M | $-4.5M | ||
| Q1 24 | $6.2M | $-4.1M |
| Q4 25 | -1263.3% | -70.5% | ||
| Q3 25 | 37.7% | -55.6% | ||
| Q2 25 | 35.6% | -73.2% | ||
| Q1 25 | 31.0% | -82.0% | ||
| Q4 24 | 38.0% | -19.3% | ||
| Q3 24 | 27.9% | -23.1% | ||
| Q2 24 | 29.1% | -20.1% | ||
| Q1 24 | 27.2% | -19.5% |
| Q4 25 | -1545.5% | -246.8% | ||
| Q3 25 | 27.4% | -40.1% | ||
| Q2 25 | 24.6% | -51.7% | ||
| Q1 25 | 22.6% | -58.9% | ||
| Q4 24 | 30.7% | -9.2% | ||
| Q3 24 | 20.5% | -11.2% | ||
| Q2 24 | 18.9% | -9.0% | ||
| Q1 24 | 19.9% | -8.7% |
| Q4 25 | $-0.68 | $-2.40 | ||
| Q3 25 | $0.27 | $-0.38 | ||
| Q2 25 | $0.24 | $-0.46 | ||
| Q1 25 | $0.19 | $-0.50 | ||
| Q4 24 | $0.27 | $-0.09 | ||
| Q3 24 | $0.16 | $-0.09 | ||
| Q2 24 | $0.14 | $-0.08 | ||
| Q1 24 | $0.15 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.0M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $690.1M | $327.2M |
| Total Assets | $5.8B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.0M | $84.9M | ||
| Q3 25 | $131.7M | $70.0M | ||
| Q2 25 | $97.6M | $81.0M | ||
| Q1 25 | $101.7M | $111.8M | ||
| Q4 24 | $167.7M | $102.3M | ||
| Q3 24 | $232.9M | $100.5M | ||
| Q2 24 | $153.5M | $103.0M | ||
| Q1 24 | $238.8M | $125.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $666.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $690.1M | $327.2M | ||
| Q3 25 | $719.6M | $466.0M | ||
| Q2 25 | $710.3M | $486.3M | ||
| Q1 25 | $711.1M | $511.4M | ||
| Q4 24 | $704.7M | $538.5M | ||
| Q3 24 | $699.6M | $541.2M | ||
| Q2 24 | $693.0M | $542.5M | ||
| Q1 24 | $698.4M | $544.0M |
| Q4 25 | $5.8B | $488.9M | ||
| Q3 25 | $5.7B | $601.1M | ||
| Q2 25 | $5.7B | $624.7M | ||
| Q1 25 | $5.7B | $631.9M | ||
| Q4 24 | $5.7B | $656.2M | ||
| Q3 24 | $5.7B | $645.1M | ||
| Q2 24 | $5.7B | $651.4M | ||
| Q1 24 | $5.9B | $652.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.95× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.7M | $-29.4M |
| Free Cash FlowOCF − Capex | $52.5M | $-29.5M |
| FCF MarginFCF / Revenue | 127.1% | -51.6% |
| Capex IntensityCapex / Revenue | 2.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $89.2M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.7M | $-29.4M | ||
| Q3 25 | $13.9M | $-31.6M | ||
| Q2 25 | $14.1M | $-15.3M | ||
| Q1 25 | $9.4M | $-33.1M | ||
| Q4 24 | $31.1M | $-1.8M | ||
| Q3 24 | $14.0M | $-14.6M | ||
| Q2 24 | $6.9M | $-6.9M | ||
| Q1 24 | $4.2M | $7.6M |
| Q4 25 | $52.5M | $-29.5M | ||
| Q3 25 | $13.6M | $-31.8M | ||
| Q2 25 | $13.9M | $-15.6M | ||
| Q1 25 | $9.2M | $-33.6M | ||
| Q4 24 | $30.0M | $-2.0M | ||
| Q3 24 | $13.7M | $-14.7M | ||
| Q2 24 | $6.7M | $-7.0M | ||
| Q1 24 | $3.8M | $7.6M |
| Q4 25 | 127.1% | -51.6% | ||
| Q3 25 | 34.6% | -56.5% | ||
| Q2 25 | 35.7% | -29.6% | ||
| Q1 25 | 26.3% | -67.1% | ||
| Q4 24 | 81.6% | -3.8% | ||
| Q3 24 | 43.2% | -30.9% | ||
| Q2 24 | 21.1% | -13.9% | ||
| Q1 24 | 12.1% | 15.9% |
| Q4 25 | 2.8% | 0.2% | ||
| Q3 25 | 0.8% | 0.3% | ||
| Q2 25 | 0.6% | 0.6% | ||
| Q1 25 | 0.7% | 0.9% | ||
| Q4 24 | 3.1% | 0.4% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 1.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NFBK
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
